EWM
GILD icon

Evolution Wealth Management’s Gilead Sciences GILD Stock Holding History

Evolution Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.82K Sell
54
-1
-2% -$132 ﹤0.01% 647
2026
Q1 		$7.67K Buy
55
+32
+139% +$4.48K 0.01% 551
2025
Q4 		$2.82K Sell
23
-36
-61% -$4.38K ﹤0.01% 614
2025
Q3 		$6.6K Sell
59
-37
-39% -$4.21K 0.01% 410
2025
Q2 		$10.7K Buy
+96
New +$10.2K 0.01% 350

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evolution Wealth Management's GILD Position: Q2 2026 in Review

Evolution Wealth Management reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $132 and leaving 54 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Evolution Wealth Management first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $10.7K in Q2 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Evolution Wealth Management held 54 shares of Gilead Sciences worth $6.82K as of Q2 2026.
  • Evolution Wealth Management sold 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up ﹤0.01% of Evolution Wealth Management's portfolio in Q2 2026, its #647 holding.
  • Evolution Wealth Management first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Evolution Wealth Management's Gilead Sciences position peaked at $10.7K in Q2 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Evolution Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.